129 related articles for article (PubMed ID: 26051544)
1. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
[TBL] [Abstract][Full Text] [Related]
2. Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.
Pradines B; Bories C; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Pharm Res; 2015 Apr; 32(4):1229-36. PubMed ID: 25319099
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
Mazzaferro S; Bouchemal K; Skanji R; Gueutin C; Chacun H; Ponchel G
J Control Release; 2012 Sep; 162(3):568-74. PubMed ID: 22902592
[TBL] [Abstract][Full Text] [Related]
5. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
[TBL] [Abstract][Full Text] [Related]
6. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
Bravo-Osuna I; Ponchel G; Vauthier C
Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles.
Moghaddam FA; Atyabi F; Dinarvand R
Nanomedicine; 2009 Jun; 5(2):208-15. PubMed ID: 19186220
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
[TBL] [Abstract][Full Text] [Related]
9. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
10. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
11. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin.
Zheng Y; Chen Y; Jin LW; Ye HY; Liu G
AAPS PharmSciTech; 2016 Dec; 17(6):1347-1352. PubMed ID: 26718819
[TBL] [Abstract][Full Text] [Related]
13. Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface.
Bravo-Osuna I; Teutonico D; Arpicco S; Vauthier C; Ponchel G
Int J Pharm; 2007 Aug; 340(1-2):173-81. PubMed ID: 17592748
[TBL] [Abstract][Full Text] [Related]
14. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
15. Gelation and micellization behaviors of pluronic(®) F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application.
Pradines B; Djabourov M; Vauthier C; Loiseau PM; Ponchel G; Bouchemal K
Colloids Surf B Biointerfaces; 2015 Nov; 135():669-676. PubMed ID: 26340355
[TBL] [Abstract][Full Text] [Related]
16. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
Patel D; Naik S; Chuttani K; Mathur R; Mishra AK; Misra A
J Drug Target; 2013 Sep; 21(8):759-69. PubMed ID: 23879335
[TBL] [Abstract][Full Text] [Related]
18. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain.
Patel D; Naik S; Misra A
J Pharm Sci; 2012 Feb; 101(2):690-706. PubMed ID: 22006260
[TBL] [Abstract][Full Text] [Related]
19. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
Chen CH; Lin YS; Wu SJ; Mi FL
Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
[TBL] [Abstract][Full Text] [Related]
20. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
